The sisomicin-gentamicin resistance methylase (sgm) gene was isolated from Micromonospora zionensis and cloned in Streptomyces lividans. The sgm gene was expressed in Micromonospora melanosporea, where its own promoter was active, and also in Escherichia coli under the control of the lacZ promoter. The complete nucleotide sequence of 1,122 bp and a transcription start point were determined. The sequence contains an open reading frame that encodes a polypeptide of 274 amino acids. The methylation of 30S ribosomal subunits by Sgm methylase accounts adequately for all known resistance characteristics ofM. zionensis, but expression of high-level resistance to hygromycin B is background dependent. A comparison of the amino acid sequence of the predicted Sgm protein with the deduced amino acid sequences for the 16S rRNA methylases showed extensive similarity to Grm and significant similarity to KgmB but not to KamB methylase.
The sisomicin-gentamicin resistance methylase (sgm) gene was isolated from Micromonospora zionensis and cloned in Streptomyces lividans. The sgm gene was expressed in Micromonospora melanosporea, where its own promoter was active, and also in Escherichia coli under the control of the lacZ promoter. The complete nucleotide sequence of 1,122 bp and a transcription start point were determined. The sequence contains an open reading frame that encodes a polypeptide of 274 amino acids. The methylation of 30S ribosomal subunits by Sgm methylase accounts adequately for all known resistance characteristics ofM. zionensis, but expression of high-level resistance to hygromycin B is background dependent. A comparison of the amino acid sequence of the predicted Sgm protein with the deduced amino acid sequences for the 16S rRNA methylases showed extensive similarity to Grm and significant similarity to KgmB but not to KamB methylase.
Antibiotic-producing organisms must be able to protect themselves against their own toxic products. Mechanisms of resistance variously employ inactivation of the products by antibiotic-modifying enzymes, alteration of the target sites to which the drugs normally bind, and the ability to exclude antibiotics from the cell (for a review, see reference 4). Much of the available data relate to inhibitors of protein synthesis that normally act against the ribosome but can be prevented from doing so in the respective producing organisms either by detoxification of the drugs or via ribosomal modification. Interestingly, whenever antibiotic-resistant ribosomes had previously been observed in producers of the respective drugs, the mechanism of resistance had invariably been shown to involve methylation of rRNA at a single site characteristic of each different phenotype (2, 24, 26) .
In the case of Micromonospora strains which produce aminoglycosides, ribosomes are at least in part responsible for the resistance phenotype and it has been shown that the 30S subunit was responsible for the resistance (17) . More specifically, it was ascertained that the state of 16S RNA in the 30S subunits from Micromonospora purpurea, the gentamicin producer, is responsible for resistance (20, 27) . Concerning genes originated in Micromonospora spp., virtually no data are available. Thus, it is not known whether the genes responsible for antibiotic biosynthesis in Micromonospora strains are organized and controlled in the same manner as in Streptomyces strains. As a first step in studying the genetic organization of antibiotic biosynthetic genes in Micromonospora strains, it was decided to clone the resistance determinant from Micromonospora zionensis, the producer of G-52 (6'-N-methyl-sisomicin) (3, 29) .
Cloning of the sgm gene in Streptomyces lividans. The M. zionensis resistance determinant was isolated by using the well-characterized expression system of the related actinomycete S. lividans (12) (12) . Among thiostrepton-resistant transformants containing BamHI inserts, three colonies were resistant to 50 ,ug of gentamicin per ml. Plasmids were isolated from transformants and subjected to restriction analysis, which revealed the presence of the same 4.5-kb insert, in either orientation, which is depicted in Fig. 1 . These plasmids conferred resistance to both gentamicin and thiostrepton when reintroduced into S. lividans TK21, and one such transformant, designated MK3, was chosen for further analysis. The sgm gene has been located within pMK3 by successive subcloning experiments in pIJ702 and also in pUC18/19 vectors. It was shown that a 1.12-kb Sa1I-SalI DNA fragment conferred resistance to gentamicin when ligated into pUC19 and introduced into Escherichia coli MN522 (8) . However, the resistance gene could be expressed only when it was in the same orientation as the lacZ promoter, suggesting that expression of the M. zionensis gene was dependent on the E. coli transcriptional signal (data not shown).
Resistance profiles of gentamicin-resistant clones. MICs of several selected aminoglycoside antibiotics were determined for S. lividans MK33 (the sgm strain, containing pMK33) and TSK1 (control strain containing pIJ702). M. zionensis was used in this experiment as well, in order to compare resistance patterns. As can be seen in Table 1 , our clone is cross resistant to kanamycin as well as to the other antibiotics of the gentamicin family. In this respect, the MIC profile for the S. lividans sgm strain closely resembled that for M. zionensis, with the exception of the hygromycin B MIC. Surprisingly, when the sgm gene was introduced into Micromonospora melanosporea protoplasts (16), transformants were resistant to hygromycin B, whereas S. lividans transformants were hygromycin sensitive (Table 1) . It was observed previously that several (if not all) producers of gentamicin-like compounds are highly resistant to hygromycin B (17, 19) . It may well be, therefore, that those organisms all share a common mode of hygromycin B resistance. We do not have enough data to account for these observations, but it is clear that expression of hygromycin B resistance determined by the sgm gene is background dependent. mutation affecting residue U-1495 gives resistance to hygromycin B in Tetrahymena thermophila (25) , so it is tempting to conclude that the U-1495 region in M. melanosporea differs from the same region of 16S rRNA in S. lividans. In other words, methylation of one residue within 16S rRNA of S. lividans confers resistance to gentamicin but not to hygromycin B, while in M. melanosporea, because of the altered context of the U-1495 region, the same gene is responsible for resistance to both gentamicin and hygromycin B. It is necessary to take into consideration the fact that various residues are all brought together in models of the secondary structure of 16S rRNA. In any event, the mapping of modified residues and sequencing of the relevant region of 16S rRNA of M. melanosporea may give an answer.
Prior to the present work, it had been already shown that ribosomes from M. zionensis were resistant in vitro to a range of aminoglycosides, which reflected the in vivo resistance phenotypes (17) . This finding suggested that the sgm allele was responsible for the ribosomal modification resulting in aminoglycoside resistance. To test this hypothesis, the S. lividans strain containing sgm on plasmid pMK3 was examined for methylase activity. Figure 2 shows that extracts from S. lividans MK3 readily methylated 30S ribosomal subunits isolated from S. lividans TSK1(pIJ702) in the presence of the methyl donor S-adenosyl-L-[methy1-H]methionine (SAM) as a cosubstrate. It was also observed that 30S ribosomal subunits from S. lividans BV1 (grn from M. purpurea [14, 28] ) were not a substrate for the methylase from the sgm strain. These data suggest that the Sgm and Grm methylases might act at a common site within 16S rRNA of the 30S ribosomal subunit. It is known that specific sites within rRNA (at which methylation or base changes resulting from mutations occur) can confer resistance to antibiotics (for a review, see reference 5). These sites are closely related to those at which ribosome-bound antibiotics give protection against chemical modification (18 DNA fragment containing sgm) was determined by the dideoxy chain termination method (22) , using either doublestranded plasmid DNA (32) or single-stranded M13 phage DNA (31) . The sequencing strategy is shown in Fig. 1 . In total, a sequence of 1,122 bp was determined, as indicated in Fig. 3 Fig. 3 ) revealed a single extension product corresponding to a G at position 143, which is 72 nucleotides upstream from the sgm coding region (Fig. 4) . The sequence in the region upstream from the TSP is not closely related to the E. coli promoter consensus sequence, which is consistent with the observation that the sgm gene cannot be expressed in E. coli under control of its own promoter. Moreover, there is an apparent difference between transcription signals of the sgm and the grmn genes. The TSP of the grn gene is located 11 nucleotides upstream of the translational start codon, while the tsp of the sgm gene is 72 nucleotides in front of ATG codon. Also, the promoter region of the grn gene shows significant 
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GCCGCGCGGGGTGACGTGCCCGACGCGGTGAAGCGCACCAAGCGGGGTCTGCACGAGATCTACGGCGCCTTCCTGCCGCCCAGCCCTCCCAACTACGCAGCGTTGCTGCGGCACCTGGAC 454 homology with conserved sequences of E. coli-like Streptomyces consensus promoters (30) . On the other hand, the promoter region of sgm differs from that known for Streptomyces or Micromonospora species (1, 21) . Furthermore, there is an indication that the sgm gene in M. zionensis is transcribed from tandem promoters: one characterized by primer extension, as shown in Fig. 4, and (14) , which could be expected since these genes have very similar phenotypes. Extensive nucleotide similarities are noted in the intragenic regions of resistance genes of three antibiotic-producing strains, but nucleotide sequences 5' to the genes showed considerable divergences. One would also expect similarities with the other 16S rRNA methylases which confer resistance to aminoglycoside antibiotics, such as kgmB and kamB products (10, 11) . Indeed, comparison of the deduced amino acid sequence revealed that there is 90, 54, and 23% identity between Sgm and the Grm, KgmB, and KamB proteins, respectively. Alignment of these amino acid sequences is shown in Fig. 5 . Since these enzymes act in a similar way and also utilize SAM as a cofactor, it would be interesting to see whether some of the regions with higher similarity are involved in coenzyme binding, as proposed for ATP sites in APH enzymes (6) . Recently, comparison of a number of very diverse SAM-dependent methyltransferases has shown that a glycine-rich motif could be involved in binding of SAM (9) . In contrast, the 16S rRNA methylases taken into consideration in this work did not show any significant sequence similarities to the proposed consensus sequence, i.e., the glycine-rich motif. On the possible explanations for that difference between 16S rRNA methylases and the other two classes of methylases (23S rRNA and DNA) is that later enzymes use naked nucleic acids as substrates, while 16S rRNA methylases could recognize only 30S ribosomal subunits and neither 16S rRNA nor 70S ribosomes. Thus, since recognition of substrates by these enzymes differs, they may also require different organization of the cofactor binding site.
Nucleotide sequence accession number. The sequence of the sgm gene has been deposited in the GenBank data base under accession number M87057.
